Phenotypes associated with this allele
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ccm2tm1Mlkn mutation
(0 available);
any
Ccm2 mutation
(47 available)
Tg(Cdh5-cre/ERT2)1Rha mutation
(3 available)
|
|
|
cardiovascular system
|
• mice injected with tamoxifen at P1 exhibit cerebral cavernous malformation lesions by P13
|
nervous system
|
• mice injected with tamoxifen at P1 exhibit cerebral cavernous malformation lesions by P13
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ccm2tm1Mlkn mutation
(0 available);
any
Ccm2 mutation
(47 available)
Nfatc1tm1.1(cre)Bz mutation
(0 available);
any
Nfatc1 mutation
(47 available)
|
|
|
mortality/aging
|
• embryonic lethality at E14.5-E15.5
|
cardiovascular system
|
• embryos exhibit a reduction in myocardial growth at E10.5
|
|
• embryos exhibit a reduction in cardiac jelly at E10.5 as indicated by reduced matrix glycosaminoglycans and versican in the heart
|
muscle
|
• embryos exhibit a reduction in myocardial growth at E10.5
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ccm2tm1Mlkn mutation
(0 available);
any
Ccm2 mutation
(47 available)
Map3k3tm1.1Mlkn mutation
(0 available);
any
Map3k3 mutation
(24 available)
Tg(Cdh5-cre/ERT2)1Rha mutation
(3 available)
|
|
|
nervous system
N |
• tamoxifen injected mice show full rescue of cerebral cavernous malformation lesion formation
(J:232707)
• tamoxifen injected mice do not exhibit cerebral cavernous malformation lesions
(J:250906)
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ccm2ltm1Mlkn mutation
(0 available);
any
Ccm2l mutation
(14 available)
Ccm2tm1Mlkn mutation
(0 available);
any
Ccm2 mutation
(47 available)
Heg1tm1Mlkn mutation
(0 available);
any
Heg1 mutation
(56 available)
Heg1tm2.1Mlkn mutation
(0 available);
any
Heg1 mutation
(56 available)
Tg(Tek-cre)1Ywa mutation
(6 available)
|
|
|
mortality/aging
|
• some survivors are detected
|